therapeutic plasma exchange market research, therapeutic plasma exchange market size, therapeutic plasma exchange market share, therapeutic plasma exchange market trends, therapeutic plasma exchange market insights, therapeutic plasma exchange market scope
At what pace is the therapeutic plasma exchange market growing, and what is its estimated value?
The therapeutic plasma exchange market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to the emergence of immunological diseases, increasing technological advancements, increased awareness and education, expanded indications, and improved understanding of the pathophysiology.
The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the rising geriatric population, clinical evidence and guidelines, regulatory environment, hospital infrastructure and healthcare investments, healthcare expenditure, and reimbursement policies. Major trends in the forecast period include personalized therapies, integration of automation, collaborative initiatives, and telemedicine integration.
Get Your Free Sample of The Global Therapeutic Plasma Exchange Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp
What are the top drivers to the rising demand in the therapeutic plasma exchange market?
The high prevalence of hematological disorders is expected to propel the growth of the therapeutic plasma exchange market going forward. Hematological disorders, also known as blood disorders, refer to medical conditions that affect the blood and blood-forming tissues, including the bone marrow, lymph nodes, and spleen. Hematological disorders are rising due to factors including genetic predispositions, environmental influences, and lifestyle changes. Therapeutic plasma exchange (TPE) is utilized in hematological disorders to remove pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thereby mitigating disease severity and improving patient outcomes. For instance, in August 2023, according to the Leukemia and Lymphoma Society, a US-based professional organization, the number of projected myeloma diagnoses is expected to rise by around 2.3% from 2021 to 2023, increasing from 34,920 to 35,730, respectively. Therefore, the high prevalence of hematological disorders is driving the growth of the therapeutic plasma exchange market.
How is the therapeutic plasma exchange market segmented?
The therapeutic plasma exchange market covered in this report is segmented –
1) By Type: Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)
2) By Indication: Neurological Disorders, Hematological Disorders, Renal Disorders, Metabolic Disorders, Other Indications
3) By Technology: Centrifugation, Membrane Separation
4) By End User: Blood Collection Centers, Hospitals And Clinics, Transfusion Centers, Other End Users
Subsegments:
1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe, Automated Tpe
2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp, Multi-Stage Dfpp
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report
Who are the top competitors in the therapeutic plasma exchange market?
Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.
What significant trends should we anticipate in the therapeutic plasma exchange market over the forecast period?
Major companies operating in the therapeutic plasma exchange market are adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in July 2022, Terumo Blood and Cell Technologies, a US-based technology company, collaborated with Eliaz Therapeutics Inc. a US-based medical device company specializing in therapeutic apheresis for inflammatory and kidney-related conditions to address acute kidney injury (AKI) and sepsis-induced AKI (S-AKI) by selectively removing the inflammatory protein Gal-3 from blood plasma. With high mortality rates associated with AKI, the collaboration aims to explore novel treatments using Terumo’s Spectra Optia Apheresis System and ETI’s XGal-3 column. Initial studies will focus on large animals before progressing to human clinical trials. Terumo, known for its innovation in therapeutic apheresis, has previously partnered on projects targeting conditions such as triple-negative breast cancer and COVID-19.
Which regional trends are influencing the therapeutic plasma exchange market, and which area dominates the industry?
North America was the largest region in the therapeutic plasma exchange market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Therapeutic Plasma Exchange Market Report 2025 Offer?
The therapeutic plasma exchange market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Therapeutic plasma exchange (TPE) refers to a medical procedure used to treat certain autoimmune diseases and other conditions. During TPE, blood is removed from the body, plasma (the liquid portion of the blood) is separated from the blood cells, and then the blood cells are returned to the body, often after being mixed with a replacement fluid. This process helps remove harmful substances from the blood, such as autoantibodies or toxins, which can contribute to various diseases.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15683
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
